Revised MRPs of 1,364 Anti-Cancer Formulations Come into Effect from Today

The NPPA capped trade margins on 137 anti-cancer drugs, with revised MRPs effective from 9th November, 2026, leading to a 96.45% maximum price reduction.

• 85 pharmaceutical companies reported revised MRPs for 1,364 anti-cancer formulations covering 121 drugs as of 8th November, 2026.
• The estimated annual savings to consumers is expected to be ₹3,540.38 crore.
• Consumers can verify prices via the Pharma Sahi Daam mobile app or the NPPA website.
• Overcharging complaints can be registered through the Pharma Jan Samadhan portal or the NPPA helpline at 1800-111-255.